Ocular Therapeutix (OCUL) Appoints Donald Notman as COO

On August 29, 2024, the board of directors of Ocular Therapeutix (NASDAQ: OCUL) appointed Donald Notman to serve as Chief Operating Officer of the Company. In addition to his new role, Mr. Notman will continue to serve as Chief Financial Officer of the Company as well as its principal financial and accounting officer.

You May Also Be Interested In

• Increasing unusual put volume: OCUL IRM ALOY DFTX WY CIA ATAI WGMI ROST SLS EQX CRWG MUU CAVA BURL D NBIG ZSL
• Google unveils Pixel 11 series with new chip and camera upgrades
• Google Pixel Watch 5 launches at $399 with new health features